Recombinant human TNF-α (rhTNF-α) and thiolated PEG were concurrently bound to the surface of 27 nanometer colloidal gold particles to generate CYT-6091 (AurimuneTM), a revolutionary tumor-targeting nanomedicine (Figure 7B) (195). This evidence concerns the gene TNF and neoplasm.